Regenix Drugs Ltd is a biopharmaceutical company located in Chennai, India, specialising in the formulation and fill-finish manufacturing of biosimilar injections. Operating within a state-of-the-art facility that spans 30,000 sq ft, Regenix is accredited by WHO-GMP and is designed in compliance with the latest GMP regulatory standards. The facility is equipped to fill sterile products in vials, pre-filled syringes (PFS), and cartridges. Currently, the company offers a range of products, including Human insulin injection (R, 30/70 & NPH), Insulin Glargine, Liraglutide, and Enoxaparin sodium injections, complemented by CTD format dossiers.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Biologics
– Formulation Development
– Regulatory Affairs Support
– Quality Assurance and Control
– Packaging Solutions
– Sterile Product Manufacturing

Regenix Drugs Ltd is committed to delivering high-quality biopharmaceutical products to meet the needs of the pharmaceutical industry. For further information about their offerings and capabilities, please visit regenixbiosciences.in.